skip to main content

    Updated Visitor Guidelines

 

MENU

 

Cancer Survivors Day

The information on this page has moved. To learn about the Survivors' Day celebration in the Ann Arbor / Washtenaw County area, please visit: https://www.cancersupportannarbor.org/survivorsday/

Developmental Therapeutics

Developmental Therapeutics Program Promotes the Advancement of Discoveries

The Developmental Therapeutics Program fosters the advancement of University of Michigan Rogel Cancer Center discoveries to translational research. Under the guidance of co-leaders Jolanta Grembecka, Ph.D., and Judith Sebolt-Leopold, Ph.D., the Developmental Therapeutics Program moves basic science discoveries to the preclinical level and aids members in moving their discoveries along the translational pipeline.

Cancer Genetics

Cancer Genetics Program Produces Innovative Collaborations

Cancer Genetics Specific Aims

Aim 1: Mechanisms
Elucidate the genetic and epigenetic mechanisms of cancer development and progression.

Aim 2: Models
Utilize novel animal model systems for characterizing the impact of critical genetic alterations found in human cancers.

Cancer Hematopoiesis and Immunology

Harnessing Stem and Immune Cell Populations for Cancer Research

Cancer Hematopoiesis and Immunology Specific Aims

Aim 1: Mechanisms
Elucidate molecular mechanisms regulating immune and non-immune hematopoietic cell function during homeostasis, cancer progression and cellular therapy.

Aim 2: Crosstalk
Understand mechanisms of cross-talk between immune cells and non-immune cells in cancer therapy and HCT.

Signaling and Tumor Microenvironment

Signaling and Tumor Microenvironment Program Leads in Translational Cancer Research

Signaling and Tumor Microenvironment Program Specific Aims

Aim 1: Signaling
Elucidate the role of cell fate and plasticity during tissue homeostasis and cancer progression.

Aim 2: Microenvironment
Define the heterocellular interactions that drive tumor epithelial growth and treatment response.

Pages